InVirtuoLabs
InVirtuoLabs aims to halve development time and costs in pharmaceutical research using artificial intelligence and advanced molecular simulations
InVirtuoLabs has raised €2.9M across 1 funding round, most recently a round in Feb 2025. Based in Lugano, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€2.9M
€2,850,000
Funding rounds
1
Investors
0
distinct backers
Active since
2025-02
latest 2025-02
Funding by year
EUR raised per yearInVirtuoLabs — funding by year — interactive chart.
Data table
| InVirtuoLabs — funding by year | |
|---|---|
| 2025 | €2.9M |
Signals
Medium confidenceRaise-next likelihood40
base rate 30% for Other
- ▲ In typical raise window
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-20 | Other | €2.9M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData